Terms: = Uterine cancer AND BUB1B, BUBR1, 701, ENSG00000156970, SSK1, BUB1beta, MAD3L, hBUBR1, Bub1A, O60566 AND Staging
3 results:
1. Establishment of a risk stratification model based on the combination of post-treatment serum squamous cell carcinoma antigen levels and FIGO stage of cervical cancer for treatment and surveillance decision-making.
Shi L; Liu Y; Li J; Kou J; Ouyang Y; Chen F; Huang X; Huo L; Huang L; Cao X
J Cancer Res Clin Oncol; 2023 Aug; 149(9):5999-6007. PubMed ID: 36624190
[TBL] [Abstract] [Full Text] [Related]
2. Prognostic value of metabolic parameters determined by preoperative ¹⁸F-FDG PET/CT in patients with uterine carcinosarcoma.
Lee HJ; Lee JJ; Park JY; Kim JH; Kim YM; Kim YT; Nam JH
J Gynecol Oncol; 2017 Jul; 28(4):e43. PubMed ID: 28541634
[TBL] [Abstract] [Full Text] [Related]
3. Costs of cervical cancer and precancerous lesions treatment in a publicly financed health care system.
Tang CH; Pwu RF; Tsai IC; Wang HI; You SL; Chen CA; Scuffham PA; Hsieh CY; Chou CY; Lin SR; Chen YD; Chen CJ
Arch Gynecol Obstet; 2010 Apr; 281(4):683-95. PubMed ID: 19730873
[TBL] [Abstract] [Full Text] [Related]
